BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/6/2017 6:30:00 PM | Browse: 100 | Download: 151
Publication Name World Journal of Gastroenterology
Manuscript ID 32280
Country of Manuscript Source Pakistan
Received
2016-12-30 09:22
Peer-Review Started
2017-01-03 16:43
To Make the First Decision
2017-02-10 08:46
Return for Revision
2017-02-13 13:07
Revised
2017-02-23 00:00
Second Decision
2017-03-09 13:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-03-15 09:57
Articles in Press
2017-03-15 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-03-23 14:05
Publish the Manuscript Online
2017-04-06 18:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Immunology
Manuscript Type Minireviews
Article Title Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Kashif Asghar, Asim Farooq, Bilal Zulfiqar and Muhammad Usman Rashid
Funding Agency and Grant Number
Correspondence To Dr. Kashif Asghar, Department of Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre, 7-A Block R-3, Johar Town, Lahore 54000, Pakistan. kashifasghar@skm.org.pk
Keywords Hepatocellular carcinoma; Hepatitis C virus, Hepatitis B virus; Indoleamine 2,3-dioxygenase
Core Tip Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme which mediates tumor immune escape in hepatocellular carcinoma (HCC). IDO up-regulation in HCC may lead to recruitment of regulatory T-cells into tumor microenvironment and therefore inhibit local immune responses and promote metastasis. IDO inhibitors as adjuvant therapeutic agents may have clinical implications in HCC.
Publish Date 2017-04-06 18:30
Citation Asghar K, Farooq A, Zulfiqar B, Rashid MU. Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma. World J Gastroenterol 2017; 23(13): 2286-2293
Url http://www.wjgnet.com/1007-9327/full/v23/i13/2286.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i13.2286
Full Article (PDF) WJG-23-2286.pdf
Full Article (Word) WJG-23-2286.doc
Revised Manuscript 32280-Review.docx
Peer-review Report 32280-Peer-reivew(s).pdf
Answering Reviewers 32280-Answering reviewers.pdf
Scientific Misconduct Check 32280-Scientific misconduct check.pdf
Scientific Editor Work List 32280-Scientific editor work list.pdf
Audio Core Tip 32280-Audio core tip.wma
Conflict-of-Interest Disclosure Form 32280-Conflict-of-interest statement.pdf
Copyright License Agreement 32280-Copyright assignment.pdf